Perioperative Fluid Management in Patients Receiving Major Abdominal Surgery - Effects of Normal Saline Versus an Acetate Buffered Balanced Infusion Solution on the Necessity of Catecholamines for Cardiocirculatory Support

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background Intraoperative hypotension is a common problem that significantly contributes to perioperative mortality and morbidity. At the moment the "gold standard" for perioperative fluid management is the so called "goal-directed therapy" that features fluid resuscitation followed if necessary catecholamines if needed for perioperative cardiocirculatory support.

Worldwide the so called "physiological" sodium chlorid (0.9% NaCl) solution is the most often used infusate for perioperative fluid management. Despite its widespread use physiological saline has its major disadvantages such as the increased incidence of metabolic acidosis. Nevertheless catecholamines have their significant side effects as well (eg diminished renal perfusion, increased cardiovascular morbidity) and they therefore should be used with caution.

In a prior study by group members on patients undergoing renal transplantation receiving either physiological saline or an acetate-buffered infusate showed a 50% decrease in catecholamine necessity in the acetate-buffered infusate group. The investigators therefore would like to evaluate the effects of the perioperative fluid choice on the necessity of catecholamine use.

Aim

* Evaluation of the perioperative fluid choice on the necessity of catecholamines for cardiocirculatory support.
* Description of the relationship between perioperative fluid choice and minimal blood pressure as well as the time to catecholamine use and their dosage.

Methods The investigators plan a prospective randomized-controlled trial of all patients undergoing major abdominal surgery at the Vienna General Hospital and Medical University of Vienna. Fluid management and catecholamine use will be based on a oesophageal Doppler -based treatment scheme.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fluid Management in Patients Undergoing Cardiac Surgery

NCT02895659

Critical Illness

COMPLETED PHASE4

Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients

NCT01309724

Hypotension

COMPLETED NA

Crystalloids Versus Colloids During Surgery

NCT00517127

Fluid Overload Postoperative Complications

COMPLETED PHASE4

Fluid Loading in Abdominal Surgery: Saline Versus Hydroxyethyl Starch (FLASH Study)

NCT02502773

Postoperative Morbidity Postoperative Mortality

COMPLETED PHASE3

Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery

NCT03278548

Hypovolaemia Due to Acute Blood Loss

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NaCl 0.9% BBraun (normale saline)

154mmol/l sodium, 154mmol/l chloride

Group Type ACTIVE_COMPARATOR

vasopressor

Intervention Type DRUG

Patients receive oesophageal doppler-based hemodynamic support either with fluid or with vasopressor

fluid bolus

Intervention Type DRUG

oesophagus doppler (CardioQ)

Intervention Type DEVICE

Normal Saline

Intervention Type DRUG

arterial cannulation

Intervention Type DEVICE

intravenous peripheral line insertion (17 gauge)

Intervention Type DEVICE

for fluid bolus administration

Elo-Mel Isoton (balanced acetat-based infusate)

sodium 140mmol/l, potassium 5.0mmol/l, calcium 2.5mmol/l, magnesium 1.5mmol/l, chlorid 108mmol/l, acetate 45mmol/l

Group Type ACTIVE_COMPARATOR

vasopressor

Intervention Type DRUG

Patients receive oesophageal doppler-based hemodynamic support either with fluid or with vasopressor

fluid bolus

Intervention Type DRUG

oesophagus doppler (CardioQ)

Intervention Type DEVICE

arterial cannulation

Intervention Type DEVICE

intravenous peripheral line insertion (17 gauge)

Intervention Type DEVICE

for fluid bolus administration

Elo-Mel Isoton (balanced acetat-based infusate)

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

vasopressor

Patients receive oesophageal doppler-based hemodynamic support either with fluid or with vasopressor

Intervention Type DRUG

fluid bolus

Intervention Type DRUG

oesophagus doppler (CardioQ)

Intervention Type DEVICE

Normal Saline

Intervention Type DRUG

arterial cannulation

Intervention Type DEVICE

intravenous peripheral line insertion (17 gauge)

for fluid bolus administration

Intervention Type DEVICE

Elo-Mel Isoton (balanced acetat-based infusate)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

phenylephrine, norepinephrine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients scheduled for open elective major abdominal surgery and expected to last a minimum of 2 hours will be included in the study.

(Major abdominal surgery includes all gynecological, urological and general surgical operations requiring laparotomy)

Exclusion Criteria

* Patients younger than 18 years of age
* Patients unable to give informed consent
* Pregnancy or breastfeeding
* Patients transferred form the intensive care unit to the operating theater
* Patients with an already established catecholamine therapy
* Emergency operation
* Chronic inflammatory diseases (chronic inflammatory rheumatoid diseases, chronic inflammatory renal diseases, chronic inflammatory infectious diseases, chronic inflammatory bowel diseases, chronic liver disease with signs of liver insufficiency)
* Severe cardiovascular disease (heart disease with an ejection fraction below 30%, instable coronary syndromes, severe valvular disease)
* Any signs of infection or sepsis
* Any contraindication for oesophageal Doppler monitoring (oesophageal and aortic pathology, planned oesophageal resection)
* Renal insufficiency with a glomerular filtration rate below 30ml/min
* Patients with additional epidural anesthesia are excluded from the study if epidural anesthesia is planned to be used for analgesia intraoperatively

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No